Single-Dose Administration Trial of TLC599 in Osteoarthritis of the Knee

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

TLC599

Single dose via intra-articular injection

Trial Locations (3)

104

MacKay Memorial Hospital, Taipei

110

Taipei Medical University Hospital, Taipei

112

Taipei Veterans General Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Taiwan Liposome Company

INDUSTRY